148 related articles for article (PubMed ID: 16028070)
41. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
[TBL] [Abstract][Full Text] [Related]
42. Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1.
McGuinness AN; Tahir A; Sutton NR; Marquis AD
Purinergic Signal; 2024 Jun; 20(3):257-271. PubMed ID: 37165287
[TBL] [Abstract][Full Text] [Related]
43. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
44. Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1.
Zebisch M; Krauss M; Schäfer P; Sträter N
J Mol Biol; 2012 Jan; 415(2):288-306. PubMed ID: 22100451
[TBL] [Abstract][Full Text] [Related]
45. Characterization of Rat NTPDase1, -2, and -3 ectodomains refolded from bacterial inclusion bodies.
Zebisch M; Sträter N
Biochemistry; 2007 Oct; 46(42):11945-56. PubMed ID: 17910474
[TBL] [Abstract][Full Text] [Related]
46. Determination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytes.
Failer BU; Aschrafi A; Schmalzing G; Zimmermann H
Eur J Biochem; 2003 Apr; 270(8):1802-9. PubMed ID: 12694193
[TBL] [Abstract][Full Text] [Related]
47. Rat, mouse, and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered purinergic signaling in the posterior eye.
Lu W; Hu H; Sévigny J; Gabelt BT; Kaufman PL; Johnson EC; Morrison JC; Zode GS; Sheffield VC; Zhang X; Laties AM; Mitchell CH
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3075-83. PubMed ID: 26024091
[TBL] [Abstract][Full Text] [Related]
48. Mechanism of Graft Damage Caused by NTPDase1-activated Macrophages in Acute Antibody-Mediated Rejection.
Peng X; Yong Z; Xiaoyan W; Yuanshan C; Guangzhu W; Xuehuan L
Transplant Proc; 2021; 53(1):436-442. PubMed ID: 32773283
[TBL] [Abstract][Full Text] [Related]
49. Impaired natriuretic response to high-NaCl diet plus aldosterone infusion in mice overexpressing human CD39, an ectonucleotidase (NTPDase1).
Zhang Y; Robson SC; Morris KL; Heiney KM; Dwyer KM; Kishore BK; Ecelbarger CM
Am J Physiol Renal Physiol; 2015 Jun; 308(12):F1398-408. PubMed ID: 25877509
[TBL] [Abstract][Full Text] [Related]
50. Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes.
Kukulski F; Komoszyński M
Eur J Biochem; 2003 Aug; 270(16):3447-54. PubMed ID: 12899702
[TBL] [Abstract][Full Text] [Related]
51. Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system.
Braun N; Sévigny J; Robson SC; Hammer K; Hanani M; Zimmermann H
Glia; 2004 Jan; 45(2):124-32. PubMed ID: 14730706
[TBL] [Abstract][Full Text] [Related]
52. Distinctive roles of endoplasmic reticulum and golgi glycosylation in functional surface expression of mammalian E-NTPDase1, CD39.
Zhong X; Kriz R; Kumar R; Guidotti G
Biochim Biophys Acta; 2005 May; 1723(1-3):143-50. PubMed ID: 15777625
[TBL] [Abstract][Full Text] [Related]
53. E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.
Souza Vdo C; Schlemmer KB; Noal CB; Jaques JA; Zimmermann CE; Leal CA; Fleck J; Casali EA; Morsch VM; Schetinger MR; Leal DB
Parasitol Int; 2012 Dec; 61(4):690-6. PubMed ID: 22846899
[TBL] [Abstract][Full Text] [Related]
54. Caveolins and heart diseases.
Panneerselvam M; Patel HH; Roth DM
Adv Exp Med Biol; 2012; 729():145-56. PubMed ID: 22411319
[TBL] [Abstract][Full Text] [Related]
55. A membrane network of receptors and enzymes for adenine nucleotides and nucleosides.
Schicker K; Hussl S; Chandaka GK; Kosenburger K; Yang JW; Waldhoer M; Sitte HH; Boehm S
Biochim Biophys Acta; 2009 Feb; 1793(2):325-34. PubMed ID: 18973777
[TBL] [Abstract][Full Text] [Related]
56. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
57. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
58. Expression and characterization of human ecto-ATPase and chimeras with CD39 ecto-apyrase.
Hicks-Berger CA; Kirley TL
IUBMB Life; 2000 Jul; 50(1):43-50. PubMed ID: 11087120
[TBL] [Abstract][Full Text] [Related]
59. The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.
El-Omar MM; Islam N; Broekman MJ; Drosopoulos JH; Roa DC; Lorin JD; Sedlis SP; Olson KE; Pulte ED; Marcus AJ
Thromb Res; 2005; 116(3):199-206. PubMed ID: 15935828
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
